<DOC>
	<DOCNO>NCT00599053</DOCNO>
	<brief_summary>Our hypothesis treatment know Ureaplasma spp . infection airways low birth weight ( VLBW ) infant azithromycin eradicate organism lessen proinflammatory state cause infection put risk BPD . We propose conduct randomize trial early ( less 3 day age ) treatment intravenous azithromycin versus expectant management VLBW infant Ureaplasma spp . respiratory tract infection follow specific aim : ( 1 ) Determine microbiological efficacy , pharmacokinetics , safety azithromycin treatment eradication Ureaplasma spp . preterm infant , ( 2 ) Determine respiratory outcome infants two treatment group without respiratory tract Ureaplasma spp . infection</brief_summary>
	<brief_title>Early Versus Expectant Treatment Ureaplasma Infection Very Low Birth Weight Neonates</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Ureaplasma Infections</mesh_term>
	<criteria>Infants weigh &lt; 1250 gram birth respiratory distress syndrome respiratory infection Ureaplasma sp organism . Severe respiratory distress syndrome survival unlikely &gt; 7 day , Congenital malformation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Ureaplasma</keyword>
	<keyword>Bronchopulmonary dysplasia</keyword>
	<keyword>low birthweight</keyword>
</DOC>